At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
FRLN Freeline Therapeutics Holdings plc
Halted 12-23 10:48:34 EST
6.48
+0.00
0.00%
High6.48
Low6.48
Vol0.00
Open6.48
D1 Closing6.48
Amplitude0.00%
Mkt Cap28.25M
Tradable Cap11.58M
Total Shares4.36M
T/O36.65K
T/O Rate0.00%
Tradable Shares1.79M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Acquisition of Freeline by Syncona Becomes Effective
Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies. It develops FLT180a for the treatment of hemophilia B.; FLT201 for the treatment of Type 1 Gaucher disease; and FLT190 for the treatment of Fabry disease. in addition, it has research programs for systemic gene therapy. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom.